Zosano Pharma Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Tech drags S&P 500, Nasdaq lower as Iran tensions, Nvidia earnings loom
- Oil slips ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Tech drags S&P 500, Nasdaq lower as Iran tensions, Nvidia earnings loom
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
- Funds sell $44bn in semiconductors on AI concerns
Ladenburg Thalmann Downgrades Zosano Pharma (ZSAN) to Neutral
August 11, 2016 6:57 AM EDTLadenburg Thalmann downgraded Zosano Pharma (NASDAQ: ZSAN) from Buy to Neutral.
For an analyst ratings summary and ratings history on Zosano Pharma click here. For more ratings news on Zosano Pharma click here.
Shares of Zosano Pharma closed at $1.39 yesterday.
... More